Bengaluru drugmaker

Indian Drugmaker To Produce 200 Million Doses Of Russian Sputnik V COVID Vaccine

Bengaluru-based drugmaker Stelis Biopharma will produce 200 million doses of Russia’s Sputnik V coronavirus vaccine. The Russian Direct Investment Fund…

March 19, 2021